CXCL10 and rheumatoid arthritis: An immunoenzymatic assay conducted by Chinese and American cohorts evaluated the use of cytokines and chemokines as biomarkers for RA-ILD, with a focus on MMP-7 and IP-10/CXCL10 [16].